D-0868-2026 Class II Ongoing
FDA drug recall D-0868-2026 was initiated by Amneal Pharmaceuticals Of New York, LLC on Aug 28, 2026 and is designated Class II. Reason for recall: Defective Delivery System: Possibility of no medication in the prefilled pen. The recall status is ongoing. Affected quantity: 5,694 pens.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 30, 2026
- Initiation Date
- Aug 28, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,694 pens
Product description
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Reason for recall
Defective Delivery System: Possibility of no medication in the prefilled pen.
Distribution pattern
USA Nationwide
Code information
Lot #: AP250095A, Exp 2/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0868-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026